A Year at the Heart of Regulatory Decision Making

by ANCEL.LA SANTOS, Senior Policy Advisor – Europe

It’s that time of year when we reflect on our activities and achievements of the last 12 months. It’s been a busy year across the organisation, and our European Projects have been no exception! Our Senior Policy Advisor, Ancel.la Santos, looks back at a year of hard work at the heart of regulatory decision making in the European Union (EU),

Medicijnen: de link met de maatschappij

Guest blog by FEMKE HEDDEMA, former HAI intern

Last week, we held a successful event in The Hague on public health and innovation in the Netherlands. The success of the event owed a lot to the hard work and dedication of our summer intern, Femke, who writes here on her experiences and what she learned working with us at HAI.

What Role Can Civil Society Play in the European Regulatory Process?

by ANCEL.LA SANTOS, Senior Policy Advisor

The formal engagement of patients and consumers in the pharmaceutical regulatory process helps ensure that important decisions about medicines take into account the thoughts and views of the people they most affect. The European Medicines Agency (EMA) has a long tradition of this kind of stakeholder involvement.

Open Science for Health: Shaping the New Framework Programme

by JAUME VIDAL, Policy Advisor - Europe Health Action International (HAI) and Commons Network were joined last week in a packed room at the European Parliament by European Union lawmakers, policy-makers and other civil society groups to debate the challenges and opportunities ahead for the medical research and development (R&D) system. Open Science for Health [...]

New Dutch Government Must Ensure Transparency to Control Medicine Prices

by JAUME VIDAL After almost seven months of negotiations, The Netherlands has formed a new coalition government, which recently outlined its priorities and main policy objectives in its Coalition Agreement. On the whole, it’s good news from an access to medicines perspective—particularly pricing and procurement, which remain high on the government’s priority list. Some of [...]

HAI’s Research into Access to Sexual and Reproductive Health Commodities Now in Full Swing

by BOBBI KLETTKE, Communications Manager

The methodology has been finalised. The pilot testing is complete. And data collection officials are trained.

Health Action International’s study into the price, availability and affordability of more than 30 sexual and reproductive health (SRH) commodities is now rolling out across all three of our study countries—Uganda,

Meet Callum Gunn: Our #InvaluableIntern & Rising TTIP Afficionado

Everyone’s heard about those internships where the main tasks are making coffee and copying and filing mountains of documents. Well, not at Health Action International (HAI)! Being an #InvaluableIntern here means you’re adopted as valued member of our team. With guidance from our staff, many of our interns conduct their own research projects on access to medicines and rational use of medicines topics to meet their course requirements.

12

START TYPING AND PRESS ENTER TO SEARCH